Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

17
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/20/2015 03/23/2015 03/24/2015 03/25/2015 03/26/2015 Date
3.98(c) 3.89(c) 3.78(c) 3.65(c) 3.73(c) Last
5 850 007 4 269 222 2 092 192 3 356 759 3 327 240 Volume
-3.63% -2.26% -2.83% -3.44% +2.19% Change
More quotes
Financials ($)
Sales 2015 36,0 M
EBIT 2015 -2,38 M
Net income 2015 -2,25 M
Debt 2015 -
Yield 2015 -
Sales 2016 0,74 M
EBIT 2016 -43,9 M
Net income 2016 -43,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 16,3x
Capi. / Sales 2016 794x
Capitalization 588 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
03/05 Leading Health Care Stock for Small-Cap Stars is Geron Corp. (GERN) for March..
03/03 GERON : reports 4Q loss
03/03 GERON : Results of Operations and Financial Condition, Costs Associated with Exi..
03/03 GERON : Reports Fourth Quarter and Annual 2014 Financial Results and Recent Even..
02/26 GERON : Announces Conference Call to Discuss Fourth Quarter and Annual 2014 Fina..
02/20 GERON : "Synthesis of Protected 3'-Amino Nucleoside Monomers" in Patent Applicat..
02/20 ASTERIAS BIOTHERAPEUTICS : Patent Issued for Primate Pluripotent Stem Cell Expan..
02/02 GERON : to Present at the 17th Annual BIO CEO & Investor Conference
More news
Sector news : Bio Therapeutic Drugs
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
03/25 Merger momentum keeps on rolling with Heinz deal for Kraft
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/20 SEEKING ALPHA'S BIOTECH WEEKLY : Biogen's Plaque Attack, Amgen Or Gilead?, And M..
03/17 Some Questions For Dr. Scarlett, CEO Of Geron
03/10 Geron getting some Acadia-stoked love
03/10 Midday Gainers / Losers
03/06 SEEKING ALPHA'S BIOTECH WEEKLY : AbbVie - Pharmacyclitics, Orexigen Confusion, A..


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF